Novostia is a privately held medical device company developing an innovative artificial heart valve, designed for patients of any age, including children.
Novostia endeavors to advance its technology to clinical trials and regulatory approvals to improve the quality of life of millions of people worldwide suffering from aortic and mitral valve disease.
For more information please visite www.novostia.com
Location: Switzerland, Neuchâtel
Employees: 1-10
Total raised: $12.03M
Founded date: 2017
Funding Rounds 3
Date | Series | Amount | Investors |
03.05.2023 | Series A | $2.76M | - |
17.01.2020 | Grant | $2.77M | - |
22.02.2019 | - | $6.5M | - |
Mentions in press and media 8
Date | Title | Description | Source |
29.11.2023 | Swiss medtech startups enter next development phase | Based in Canton Berne, Compremium is developing diagnostic solutions for pressure-related conditio... | startuptic... |
03.05.2023 | Novostia raises EUR 2.5M in Series A | Novostia SA, a clinical stage company developing a breakthrough artificial heart valve, has just r... | startuptic... |
10.09.2021 | First Biopôle Start-up Fund recipients announced | The first recipients of the Biopôle Start-Up Fund have been announced. Novostia and Genknowme will... | startuptic... |
31.01.2020 | EIC Accelerator grants for Swiss startups | Launched in June 2019, the EIC Accelerator, previously known as SME Instrument, is for the first tim... | startuptic... |
31.01.2020 | EIC Accelerator grants for Swiss startups | Launched in June 2019, the EIC Accelerator, previously known as SME Instrument, is for the first t... | startuptic... |
22.02.2019 | Medtech start-up Novostia raises CHF 6.5 million | Heart valve diseases affect more than 100 million people worldwide. Every year hundreds of thousan... | startuptic... |
09.04.2018 | Bilan: 50 Startups to invest in | Out of 141 submitted entries, the jury selected 50 startups, 98 percent of which are new to the Bi... | startuptic... |
- | Novostia | “Accueil | Novostia” | fastfounde... |